The purpose of this study is to assess the glycaemic controlling effects of BSG and bio-transformed BSG-containing biscuits in Singapore adults with MetS. The investigators hypothesized that consumption of BSG and bio-transformed BSG containing biscuit will improve glycaemic control.
This is a double-blind, randomised, crossover experiment. During the 3-week, 19 subjects will participate in a 3 meal tolerance test (MTT). During each MTT session, all subjects are required to consume 90 g biscuits (either control, autoclaved BSG or bio-transformed BSG biscuits) and monitored over a period of 240 minutes. All three types of biscuits will be consumed at a randomised sequence during this 3-week period. Post-prandial blood glucose, insulin, lipid and amino acid responses, breath analysis, body composition, blood pressure, appetite assessment, and any other glycaemic biomarkers will be assessed.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Enrollment
16
Consumption of autoclaved BSG-containing biscuits as breakfast.
Consumption of bio-transformed BSG-containing biscuits as breakfast.
Consumption of plain biscuits as breakfast.
Yujing Xu
Singapore, Singapore
Change in blood glucose concentration
Glucose concentration in the blood will be measured
Time frame: Every week (week 1, week 2 and week 3)
Change in blood insulin concentration
Insulin concentration in the blood will be measured
Time frame: Every week (week 1, week 2 and week 3)
Change in blood triglyceride concentration
Triglyceride concentration in the blood will be measured
Time frame: Every week (week 1, week 2 and week 3)
Change in blood cholesterol concentration
Total cholesterol concentration in the blood will be measured
Time frame: Every week (week 1, week 2 and week 3)
Change in blood Low-density Lipoprotein-cholesterol (LDL) concentration
Low-density Lipoprotein-cholesterol concentration in the blood will be measured
Time frame: Every week (week 1, week 2 and week 3)
Change in High-density Lipoprotein-cholesterol (HDL) concentration
High-density Lipoprotein-cholesterol concentration in the blood will be measured
Time frame: Every week (week 1, week 2 and week 3)
Change in blood amino acid concentration
Amino acid concentration in the blood will be measured
Time frame: Every week (week 1, week 2 and week 3)
Change in appetite assessed by visual analogue scale
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Visual analogue scale will be used to assess appetite.
Time frame: Every week (week 1, week 2 and week 3)
Change in breath CH4 and H2 concentrations
CH4 and H2 concentrations will be measured by breath analyzer
Time frame: Every week (week 1, week 2 and week 3)
Change in weight and height
Weight (in kilograms) and height (in meters) will be combined to report BMI in kg/m\^2
Time frame: Every week (week 1, week 2 and week 3)
Change in waist circumference
Waist circumference (in cm) will be measured
Time frame: Every week (week 1, week 2 and week 3)
Change in blood pressure
Systolic and diastolic blood pressure (in mmHg) will be measured by a blood pressure monitor.
Time frame: Every week (week 1, week 2 and week 3)